Akebia Therapeutics (AKBA) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of ...
Akebia Therapeutics Inc. (AKBA) on Wednesday reported a second-quarter loss of $8.9 million, after reporting a profit in the ...
MarketBeat on MSN
Akebia Therapeutics Q2 earnings call highlights
Akebia Therapeutics Surges on FDA Approval for Anemia Treatment Akebia Therapeutics (NASDAQ:AKBA) reported second-quarter ...
We recently published a list of Thursday’s 10 Worst-Performing Stocks. In this article, we are going to take a look at where Akebia Therapeutics Inc. (NASDAQ:AKBA) stands against other Thursday’s ...
Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Is Akebia Therapeutics (AKBA) one of those stocks right now? A quick glance at the ...
Akebia Therapeutics Inc. Annual stock financials by MarketWatch. View the latest AKBA financial statements, income statements and financial ratios.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results